Singh Biotechnology is developing novel camelid–derived single domain antibodies that target key intracellular molecular switches in cancer. The technology has therapeutic applications beyond ...

Originally derived from camelid heavy chain antibodies, single domain or VHH antibodies can bind epitopes that are inaccessible to conventional monoclonal antibodies due to their small size. Because ...

The family of Camelidae possess a unique repertoire of fully functional antibodies, which are naturally devoid of light chains. Since the discovery of camelid heavy chain antibodies in the early 90’s, ...

ExeVir is not the first company to spin out of VIB to focus on camelid antibodies. Ablynx, which is now a subsidiary of Sanofi following a $4.8 billion acquisition at the end of 2018 ...

Nanobodies: Nanobodies are single-domain antibodies obtained from camelid antibodies. They are small in size and can bind to cryptic epitopes. Antibody-Drug Conjugates (ADCs): These antibodies are ...